Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024. In the quarter to June 2026, revenue grew 17.2%, EPS grew 36.4% and free cash flow fell 3.03%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for ten.

618.47 10.13 −1.61%
Market cap
$17.6B
P/E
35.6×
Fwd P/E
26.7×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
30.45 29.57 35.87 35.07

+8 more quarters

P/S ratio
5.36 5.10 6.40 6.13
P/FCF ratio
21.11 19.21 23.76 21.38
P/Operating CF
92.10 89.99 84.10 58.76
P/B ratio
34.39 22.83 35.29 49.27
EV/Sales
5.22 4.90 6.25 6.06
EV/EBITDA
23.77 22.19 28.09 26.69
EV/FCF
20.56 18.45 23.19 21.12
Current Ratio
0.73 0.85 0.74 0.57
Net Debt/EBITDA
(3.27) (4.40) (3.10) (1.92)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
3.28% 3.38% 2.79% 2.85%
Free Cash Flow Yield
4.74% 5.21% 4.21% 4.68%
Free Cash Flow per Share
4.90 5.10 6.52 8.37
Book value per Share
15.40 21.03 15.91 10.44
Free Cash Flow
138.10 144.97 188.12 235.50
EV/EBIT
24.90 23.30 29.56 28.19
Other line items

Show all line items

Columns are period end dates